Similar Articles
271 Precision targeting in hepatocellular carcinoma: Exploring ligand-receptor mediated nanotherapy
272 Effects of SARS-CoV-2 infection on incidence and treatment strategies of hepatocellular carcinoma in people with chronic liver disease
273 Identification of immune cell-related prognostic genes characterized by a distinct microenvironment in hepatocellular carcinoma
274 From prediction to prevention: Machine learning revolutionizes hepatocellular carcinoma recurrence monitoring
275 Progress in the treatment of advanced hepatocellular carcinoma with immune combination therapy
276 Prognostic value of circulating tumor cells combined with neutrophil-lymphocyte ratio in patients with hepatocellular carcinoma
277 Prohibitin 1 inhibits cell proliferation and induces apoptosis via the p53-mediated mitochondrial pathway in vitro
278 Comprehensive analysis of the protein phosphatase 2A regulatory subunit B56ε in pan-cancer and its role and mechanism in hepatocellular carcinoma
279 Leveraging machine learning for early recurrence prediction in hepatocellular carcinoma: A step towards precision medicine
280 Current status of magnetic resonance imaging radiomics in hepatocellular carcinoma: A quantitative review with Radiomics Quality Score
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA